Every constituent, scored 0–10 on Downside Risk (lower = safer), Growth Quality, and Exponential Potential, with price, YTD, a base-case fair value (and its bear–bull range), and a one-line take. Click a ticker for the full interactive report. ← research hub
◆ Accumulation band for XLF itself: roughly $53–$56 — the index is richly priced, so dollar-cost-averaging on dips toward the 50/200-day average (near $53) beats chasing new highs.
XLF (market-cap-weighted) vs RSPF (equal-weight), both rebased to 100 a year ago. When the cap-weighted line pulls ahead, the biggest names are carrying the index. Past year: XLF +6% vs RSPF +6% — a -0 pt spread, so cap- and equal-weight are roughly in line — balanced.
How many of the 1 names are actually participating — a check on whether the index is broad-based or driven by a handful of mega-caps. Right now breadth looks narrow — mega-cap-driven.
| Name | Verdict | Risk | Growth | Exp | Price | YTD | Fair value (range) | Entry zone | One-line take |
|---|---|---|---|---|---|---|---|---|---|
| MA Mastercard Incorporated | Buy — Core | 4 | 9 | 4 | — | -5.5% | $610 ($430–$760) | — | Mastercard is a rational-duopoly toll bridge on global digital payments — FY25 revenue $32.8B (+16%), 83% gross margin, 59% operating margin, net income $15.0B, and a value-added-services leg growing 22% — owned as a core quality-compounder at a full-but-not-absurd 27× forward, with the whole call… |
| V Visa Inc. | Buy — Core | 4 | 8 | 4 | — | +3.3% | $400 ($300–$470) | — | Visa is the closest thing public markets have to a toll booth on global commerce — 81% gross margin, 52% net margin, 59% ROE, net-debt/EBITDA 0.4× — and the expert panel and the quant screen agree it is a top-tier quality compounder; the only real debate is price (31× trailing, RSI 86) and the… |
| CBOE Cboe Global Markets, Inc. | Buy — Core | 3 | 7 | 4 | — | -0.8% | $287 ($192–$384) | — | CBOE is a genuinely wide-moat, net-cash, ~25%-ROE derivatives-exchange monopolist (proprietary SPX and VIX options) that just posted a record quarter (net revenue +29%, EPS +54%) and *raised* guidance — yet the stock is down 32% from its high on fears that perpetual futures and tokenization will… |
| CME CME Group Inc. | Buy — Core | 3 | 7 | 2 | — | -13.4% | $309 ($215–$384) | — | CME is the toll-booth on global derivatives — an 88%-EBITDA-margin, net-cash monopoly with vertically integrated clearing — that the market has marked down 28% on rate-cut and crypto-displacement fears; at 20× trailing and a 4.8% dividend the risk/reward has flipped attractive for a Tactical buy… |
| BLK BlackRock, Inc. | Buy — Core | 4 | 7 | 4 | — | -7.0% | $1175 ($850–$1450) | — | The world's largest asset manager ($13.9T AUM) is quietly re-shaping itself into a private-markets and technology firm via the GIP and HPS acquisitions — trading at a below-market ~18× forward earnings after a 17% pullback, which makes it a reasonable *tactical* buy for patient capital, tempered by… |
| SCHW The Charles Schwab Corporation | Buy — Core | 4 | 7 | 4 | — | -2.9% | $112 ($78–$140) | — | Schwab is the dominant US retail brokerage/custody platform whose earnings are visibly re-inflating (Q1'26 adjusted EPS $1.43, +38% YoY; net revenue record $6.5B, +16%) as the 2023 rate shock rolls off and the net interest margin re-expands — a good-quality, net-cash compounder trading at a… |
| SPGI S&P Global Inc. | Buy — Core | 4 | 7 | 3 | — | -15.8% | $545 ($360–$630) | — | SPGI is one of the best businesses in the S&P 500 — a toll-booth oligopoly (Ratings + Indices) throwing off 70% gross and 44% EBIT margins with ~$5.5B of free cash flow — that has quietly de-rated ~22% off its high as debt-issuance and FX tailwinds cooled; at ~23× forward adjusted EPS with a… |
| MSCI MSCI Inc. | Buy — Tactical | 6 | 8 | 4 | — | +5.1% | $680 ($460–$835) | — | MSCI is a toll-road on global investing — an 82%-gross-margin index-and-analytics franchise with 95% retention and pricing power — but at 34× trailing earnings with growth easing into the high-single digits and the Street's own targets sitting essentially *at* today's price, there is no margin of… |
| AMP Ameriprise Financial, Inc. | Buy — Tactical | 4 | 6 | 3 | — | -0.2% | $600 ($430–$780) | — | Ameriprise is a high-quality, US-centric wealth-and-asset manager throwing off a 54% return on equity and buying back ~5% of its stock a year, trading at a genuinely cheap ~12× trailing / ~10× FY27E earnings — but with no expert panel behind it and earnings structurally tied to equity markets and… |
| AIG American International Group, In | Buy — Tactical | 3 | 5 | 2 | — | -7.2% | $88 ($63–$108) | — | AIG has finished its decade-long shrink-and-simplify into a leaner, US-anchored property-casualty underwriter that is finally posting a sub-90% combined ratio (87.3% in Q1'26) and a low-double-digit core ROE — and it trades at ~1.06× book and ~9× forward earnings, which is genuinely cheap; but this… |
| MTB M&T Bank Corporation | Buy — Tactical | 3 | 5 | 2 | — | +18.6% | $272 ($190–$319) | — | M&T is a conservatively run, cheaply valued ($14× trailing, 1.4× book, ~2.5% yield) Northeast regional bank earning a solid ~15% ROE and buying back stock — a quality income-and-value holding, but with the shares near 52-week highs and the Street modeling roughly zero upside to consensus, the… |
| PFG Principal Financial Group, Inc. | Buy — Tactical | 4 | 5 | 2 | — | +25.7% | $123 ($88–$145) | — | Principal is a cheap, well-capitalized retirement/asset-management + benefits franchise ($770B AUM, $1.8T AUA) throwing off a ~2.9% dividend and buying back stock — but it grows revenue at mid-single digits, that growth is *slowing not speeding up*, it has no expert coverage to lean on, and it… |
| USB U.S. Bancorp | Buy — Tactical | 4 | 5 | 2 | — | +15.7% | $68 ($46–$82) | — | USB is a cheap (~13× earnings, ~2× tangible book), A-rated super-regional bank throwing off a 3.4% dividend and a 17% return on tangible common equity, with a genuine self-help efficiency story (efficiency ratio 58.2%, 440bps of positive operating leverage in Q1'26) — a reasonable value/income buy… |
| WFC Wells Fargo & Company | Buy — Tactical | 4 | 5 | 3 | — | -8.3% | $96 ($66–$116) | — | Wells Fargo is a cheap, de-risked megabank three years into a genuine expense-and-controls turnaround under Charles Scharf: with the Fed's asset cap now behind it, the story is buyback-driven ~12% EPS growth and a re-rating toward peers — a tactical value/self-help buy, not a durable compounder… |
| C Citigroup Inc. | Buy — Tactical | 5 | 5 | 3 | — | +19.9% | $158 ($96–$205) | — | Citi is the cheapest of the US money-center banks — trading at ~1.15× book and ~12.8× forward earnings — because it is still *mid-turnaround*: Jane Fraser's simplification is lifting return on tangible common equity from a dismal ~9% toward a 10–11% 2026 target and low-to-mid-teens beyond, and if… |
| HBAN Huntington Bancshares Incorporat | Buy — Tactical | 5 | 5 | 3 | — | +2.9% | $20 ($13–$25) | — | Huntington is a cheap (13× earnings, ~book value), low-beta super-regional bank that just doubled its Texas/South footprint through the Veritex and Cadence acquisitions — the numbers are solid (NIM rising to 3.24%, NCOs low at 0.26%, CET1 10.2%) but the growth is bought, not organic, ROA is still… |
| SYF Synchrony Financial | Buy — Tactical | 5 | 5 | 3 | — | -8.5% | $94 ($63–$114) | — | Synchrony is a well-run but deeply cyclical private-label credit-card lender trading at ~8× earnings and buying back a fifth of its market cap — a genuinely cheap return-of-capital story where the "growth" is share-count shrinkage, not a bigger business, and the whole call lives or dies on the US… |
| IVZ Invesco Ltd. | Buy — Tactical | 6 | 5 | 3 | — | +2.8% | $31 ($21–$39) | — | Invesco is a genuine, quiet turnaround — 11 straight quarters of positive organic inflows, the QQQ open-end conversion lifting captured fees, a de-levering balance sheet and a raised dividend — but it is still a mature, cyclical, high-beta asset manager in a fee-compressing industry, so it earns a… |
| IBKR Interactive Brokers Group, Inc. | Watch | 5 | 8 | 6 | — | +42.0% | $96 ($64–$128) | — | The lowest-cost, most-automated broker on earth is compounding accounts at +31% a year with almost no marketing spend and ~90% pretax margins — a genuine flywheel — but you are paying 39× earnings for a business where more than half of net revenue is net interest income that shrinks when the Fed… |
| AJG Arthur J. Gallagher & Co. | Watch | 5 | 7 | 4 | — | -2.5% | $268 ($210–$320) | — | Gallagher is one of the best-run serial compounders in the market — 24 straight quarters of double-digit adjusted EBITDAC growth, a low-beta recurring-commission model, and a proven M&A machine — but after a massive debt-and-equity-funded AssuredPartners acquisition the balance sheet is more… |
| NDAQ Nasdaq, Inc. | Watch | 5 | 7 | 4 | — | -12.8% | $98 ($70–$120) | — | Post-Adenza, Nasdaq has quietly become a recurring-revenue financial-technology and index business bolted onto a still-cyclical exchange — Q1'26 net revenue +14%, ARR $3.2B +13%, FinTech +20% — trading at a mid-teens forward P/E after a 16% drawdown; the setup is a reasonably priced quality… |
| ACGL Arch Capital Group Ltd. | Watch | 3 | 6 | 2 | — | +6.5% | $112 ($85–$130) | — | Arch is a genuinely excellent, disciplined P&C/reinsurance/mortgage underwriter trading at just 7.5× earnings and 1.5× book with a 20% ROE and a near-debt-free balance sheet — the problem is you're buying it at the *top* of a hard market, so consensus has FY26–28 EPS drifting *down*, not up; the… |
| AIZ Assurant, Inc. | Watch | 4 | 6 | 3 | — | +16.0% | $290 ($220–$355) | — | Assurant is a cheap, low-beta, well-managed specialty insurer whose Global Lifestyle engine (phone protection, extended warranties, vehicle plans) compounds steadily and whose Housing arm throws off catastrophe-lumpy but high-return cash — but after a +41% run to a fresh 52-week high with RSI at 78… |
| ICE Intercontinental Exchange, Inc. | Watch | 4 | 6 | 3 | — | -17.9% | $178 ($110–$215) | — | A wide-moat, cash-gushing exchange-and-data toll road (FY25 net revenue growth double-digit, 51% EBITDA margin, ~$4.3B FCF) that the market has repriced ~30% below its 52-week high on fears that perpetual futures will cannibalize its listed-futures franchise — a fear the one expert in our KB calls… |
| JPM JPMorgan Chase & Co. | Watch | 4 | 6 | 3 | — | +3.8% | $355 ($250–$430) | — | JPMorgan is the best-run large bank in the world — FY25 net income $57B, 1Q26 ROTCE 23%, a fortress 14.3% CET1 capital ratio — trading at a reasonable ~14× forward earnings, so you are paid to own a genuine quality compounder with heavy capital return; the whole call rests on the credit cycle… |
| MRSH Marsh & McLennan Companies, | Watch | 4 | 6 | 2 | — | -3.8% | $205 ($155–$238) | — | Marsh & McLennan is one of the best-run, most recession-resilient businesses in the S&P 500 — a global insurance-brokerage and consulting toll-booth with 26% ROE, low beta, and 15+ years of steady compounding — but it is a *mature* mid-single-digit organic grower trading right at fair value, so the… |
| RJF Raymond James Financial, Inc. | Watch | 4 | 6 | 3 | — | +1.3% | $178 ($128–$214) | — | Raymond James is a well-run, conservatively-financed wealth-management and capital-markets franchise trading at a reasonable ~15× earnings with a net-cash balance sheet and 17% ROE — a quality business at a fair (not cheap) price, which is why the honest call is Watch, not Buy: there is no expert… |
| WTW Willis Towers Watson Public Limi | Watch | 4 | 6 | 2 | — | -12.9% | $305 ($225–$365) | — | WTW is a high-quality, low-beta global insurance broker and HR-benefits consultant earning a 21% ROE and a rich free-cash-flow yield, but FY25 revenue slipped to $9.71B (−2%), the growth is carried by buybacks and margin rather than demand, and at ~$286 — below its own 200-day average — the stock… |
| AON Aon plc | Watch | 5 | 6 | 3 | — | +1.3% | $375 ($300–$445) | — | Aon is one of the best businesses in the S&P 500 — a global insurance-broking oligopolist with 45% ROE, 39% adjusted operating margins and sticky recurring fee revenue — but after the ~$13B NFP acquisition inflated the FY25 headline (+9.4%), the *underlying* engine is a ~5% organic grower, the… |
| COF Capital One Financial Corporatio | Watch | 5 | 6 | 4 | — | -15.4% | $255 ($175–$315) | — | Capital One just swallowed Discover — the transformational 2025 acquisition roughly doubled the share count, loaded the balance sheet with goodwill, and buried 2025 GAAP EPS under a one-time CECL reserve build — so the stock screens optically expensive on trailing GAAP but sits at only ~10× FY26E… |
| FDS FactSet Research Systems Inc. | Watch | 5 | 6 | 3 | — | -13.8% | $274 ($200–$352) | — | FactSet is a genuinely elite recurring-revenue business (95%+ subscription retention, 51% gross margin, 27% ROE) that the market has cut nearly in half in a year over two real worries — growth has slowed to ~7% and generative AI could erode the terminal moat — leaving a quality franchise at a… |
| HOOD Robinhood Markets, Inc. | Hold | 7 | 8 | 7 | — | -0.3% | $118 ($58–$175) | — | Robinhood has crossed the line from meme-stock brokerage to a genuinely profitable, fast-compounding financial super-app (FY25 revenue $4.47B +52%, net income $1.88B, 41% net margin, ROE 22%) — the growth and product velocity are real, but you are paying 53× trailing for a business whose top line… |
| BX Blackstone Inc. | Hold | 6 | 7 | 5 | — | -20.4% | $127 ($83–$164) | — | Blackstone is the world's largest alternative asset manager (~$1.3T AUM, record inflows) with a genuine fee-related-earnings moat — but the stock is down ~20% over the past year, GAAP optics (31× P/E) overstate the valuation, and the honest read is a high-quality *cyclical* trading near mid-cycle… |
| KKR KKR & Co. Inc. | Hold | 6 | 7 | 6 | — | -26.4% | $118 ($70–$165) | — | KKR is a genuinely elite alternative-asset compounder (fee-related earnings and adjusted EPS growing ~20% YoY) whose stock has been cut ~39% from its high on private-credit-cycle fears — so the debate is *cyclical dip vs. cracking cycle*, and the honest answer is that the fundamentals say buy while… |
| MCO Moody's Corporation | Hold | 6 | 7 | 3 | — | -4.0% | $500 ($385–$610) | — | Moody's is one of the highest-quality franchises in the S&P 500 — a ratings duopoly with 67% MIS margins plus a growing subscription-analytics annuity (MA ARR +8%) — but at 35× trailing on ~11% forward EPS growth the stock is priced for perfection while the shares have gone nowhere for a year (−2%… |
| ARES Ares Management Corporation | Hold | 7 | 7 | 5 | — | -27.7% | $176 ($96–$240) | — | Ares is a top-tier alternative-asset manager ($644B AUM, growing fee-related earnings) whose stock has been cut ~40% on fears that the $1.7T private-credit boom is turning — leaving it cheap on *forward adjusted* earnings (~16× FY27E) but squarely a bet on the credit cycle, which is exactly why our… |
| CB Chubb Limited | Hold | 3 | 6 | 3 | — | +15.7% | $355 ($270–$430) | — | Chubb is one of the best-underwritten, most disciplined global P&C insurers on earth — fortress balance sheet, ~20% core operating return on tangible equity, low beta — but it's a mature, cyclical compounder trading *above* its own Street price target at a 52-week high with an overbought tape, so… |
| WRB W. R. Berkley Corporation | Hold | 3 | 6 | 2 | — | +2.8% | $74 ($58–$88) | — | WRB is one of the best-run specialty commercial insurers in the market — 21% ROE, a record-low underwriting combined ratio, a fortress balance sheet and 0.31 beta — but at 16× earnings and 2.9× book near the top of a hard pricing cycle, the price already reflects the quality; it is a Watch until… |
| AXP American Express Company | Hold | 4 | 6 | 3 | — | -4.9% | $360 ($270–$445) | — | American Express is a best-in-class, self-funded premium-consumer franchise — 35% ROE, fortress CET1 10.5%, double-digit billed-business growth, ~13% forward EPS CAGR — but at 22× trailing / 20× forward with the stock overbought (RSI 84) and lagging the market, the risk/reward is roughly balanced.… |
| PGR The Progressive Corporation | Hold | 4 | 6 | 3 | — | +2.0% | $232 ($155–$272) | — | Progressive is one of the best-run insurers on earth — 39.6M policies in force (+9% YoY), a sub-87% combined ratio, and a 35% ROE — but you are buying it after a cycle-peak underwriting year, the shares are −12% over the past year despite the S&P +21%, RSI is 79 (overbought), and the Street's own… |
| MS Morgan Stanley | Hold | 5 | 6 | 3 | — | +20.5% | $218 ($150–$275) | — | Morgan Stanley is a genuinely better business than it was a decade ago — the Gorman-built, fee-annuity wealth franchise (~$2.8T fee-based assets, +$118B net new assets in a single quarter) now steadies the cyclical institutional-securities engine — but after a record 2025–26 the stock trades at… |
| APO Apollo Global Management, Inc. | Hold | 6 | 6 | 4 | — | -18.1% | $144 ($96–$171) | — | Apollo screens genuinely cheap on the earnings the Street actually underwrites (~11–13× forward adjusted EPS vs a ~16% growth path), and its Athene-driven perpetual-capital engine is a real structural moat — but the stock is in a clean downtrend, the balance sheet is an opaque insurance book, and… |
| BRO Brown & Brown, Inc. | Hold | 6 | 6 | 3 | — | -12.2% | $84 ($60–$106) | — | Brown & Brown is a high-quality, low-beta, serially-acquisitive insurance broker that just made its largest-ever acquisition (Accession/RSC, ~$7.8B) — the deal doubled goodwill and pushed net-debt/EBITDA to ~3.3×, and it landed exactly as organic growth fell to zero; the stock has already de-rated… |
| HIG The Hartford Insurance Group, In | Hold | 3 | 5 | 2 | — | +0.0% | $150 ($110–$178) | — | The Hartford is a disciplined, cheap (9.5× earnings), low-beta P&C-plus-benefits insurer earning a 20% core ROE — a genuinely high-quality operator, but it trades right on top of the Street's target with only single-digit upside, so it is a Watch: own it for ballast and yield if you already do, but… |
| BNY The Bank of New York Mellon Corp | Hold | 4 | 5 | 3 | — | +26.3% | $150 ($110–$185) | — | BNY is the world's largest custodian ($59.4T of assets under custody/administration) running at record efficiency — 1Q26 ROTCE ~29%, +42% EPS growth, a fresh $10B buyback — but after a +62% twelve-month run the stock sits right on the Street's consensus, so it is a quality utility to own for… |
| MET MetLife, Inc. | Hold | 4 | 5 | 3 | — | +14.1% | $99 ($72–$122) | — | MetLife is a large, cheap, conservatively-capitalized global life insurer trading at ~9× forward adjusted EPS with a ~2.5% dividend and steady buybacks; the numbers support a modest Buy — Tactical on valuation and capital return, but this is a low-growth, rate-sensitive balance-sheet business with… |
| NTRS Northern Trust Corporation | Hold | 4 | 5 | 3 | — | +29.2% | $182 ($128–$226) | — | Northern Trust is a rock-solid, deposit-funded custody-and-wealth franchise trading at a modest ~16× forward earnings after a strong 2025–26 recovery in return-on-equity; the earnings recovery is real but is driven by cost discipline, buybacks and a friendly rate/market backdrop rather than an… |
| PYPL PayPal Holdings, Inc. | Hold | 4 | 5 | 3 | $45 | -22.1% | $58 ($32–$85) | — | PayPal is a cash-machine at a distressed price — 8.5× earnings, ~14% free-cash-flow yield, a fortress-lite balance sheet and $6B/yr of buybacks shrinking the share count — but the market is (rightly) worried that its high-margin branded-checkout franchise is losing share to Apple Pay, Shop Pay and… |
| TRV The Travelers Companies, Inc. | Hold | 4 | 5 | 2 | — | +18.0% | $330 ($255–$400) | — | Travelers is a genuinely elite P&C underwriter — 88.6% combined ratio, 22.7% trailing core ROE, 22 straight years of dividend hikes, a fortress balance sheet — but the stock is at its 52-week high, RSI 89, trading *above* the Street's $310 target, and Wall Street's own EPS estimates show earnings… |
| CFG Citizens Financial Group, Inc. | Hold | 5 | 5 | 3 | — | +21.5% | $72 ($52–$90) | — | Citizens is a well-run, cheaply-priced US super-regional bank in the early innings of a self-help earnings recovery (NIM expanding to 3.14%, ROTCE back to 12.2%, a fast-growing Private Bank), but it is a rate- and credit-cycle business with a fixed deposit footprint — the stock has already run +54%… |
| ERIE Erie Indemnity Company | Hold | 5 | 5 | 3 | — | -9.6% | $255 ($180–$320) | — | Erie Indemnity is a capital-light, zero-debt fee machine with ~25% ROE — a genuinely high-quality toll-taker — but the stock sits at 21× earnings on EPS that has *stopped* accelerating (2025 EPS actually fell), after a −52% peak-to-trough drawdown, so at ~$259 we see it as roughly fairly valued and… |
| FITB Fifth Third Bancorp | Hold | 5 | 5 | 3 | — | +22.1% | $60 ($44–$74) | — | Fifth Third is a cleanly-run, cheap ($57, ~11.6× FY27E, 2.8% yield) super-regional that just bought Comerica in a ~$12.7B all-stock deal — the numbers are fine and the stock is near highs, but there is no expert conviction behind it and no exponential story, so it is a Watch: a reasonable… |
| GL Globe Life Inc. | Hold | 5 | 5 | 2 | — | +29.1% | $175 ($120–$225) | — | Globe Life is a cheap, low-beta, buyback-driven life & supplemental-health insurer to lower-middle-income US households — a real ~20%-ROE cash machine trading at ~12× earnings — but it grows slowly (~5% revenue), carries an unresolved agent-misconduct/short-seller overhang, and just ran +44% into a… |
| PNC The PNC Financial Services Group | Hold | 5 | 5 | 3 | — | +19.5% | $255 ($180–$293) | — | PNC is a high-quality, US-super-regional bank trading at a fair-to-slightly-cheap ~14.5× earnings with a 2.7% dividend; the numbers are solid (12% ROE, 12% forward EPS growth, low beta) but there is no expert conviction and no exponential story here — it's a Watch: own it for income and stability… |
| STT State Street Corporation | Hold | 5 | 5 | 2 | — | +32.3% | $176 ($120–$220) | — | State Street is a cheap, well-capitalized, 233-year-old custody bank and index-fund manager (SPDR) with a fortress franchise ($53.8T assets under custody, $5.67T AUM) — but its revenue rides equity markets and interest rates rather than a growth engine, so at ~13× forward earnings it is a… |
| GS The Goldman Sachs Group, Inc. | Hold | 6 | 5 | 3 | — | +16.2% | $1015 ($660–$1300) | — | Goldman is executing exceptionally well right now — record $3.65T assets under supervision, a record Global Banking & Markets quarter, 21% ROTE — and the stock is genuinely cheap on earnings (~18× trailing, ~17× forward), but those earnings sit near the top of the investment-banking/trading cycle… |
| COIN Coinbase Global, Inc. | Hold | 9 | 5 | 6 | — | -26.8% | $175 ($80–$360) | — | Coinbase is the best-capitalized, most-regulated on-ramp to crypto and owns real structural franchises (USDC/stablecoins, custody, derivatives, onchain infra) — but the stock is down ~61% from its high, earnings swing to GAAP losses on crypto-asset marks, and the forward EPS path is so dispersed… |
| BRK-B Berkshire Hathaway Inc. | Hold | 3 | 4 | 2 | — | +1.0% | $540 ($445–$595) | — | Berkshire is the definition of a fortress balance sheet — ~$373B in cash and Treasuries, $176.9B of insurance float, a diversified engine of insurance, rail (BNSF), energy, and manufacturing — trading at a reasonable ~15× earnings and 1.5× book; but with revenue essentially flat, low-double-digit… |
| CINF Cincinnati Financial Corporation | Hold | 4 | 4 | 2 | — | +17.6% | $178 ($150–$205) | — | Cincinnati Financial is a genuinely well-run, A+-rated, net-cash property-casualty insurer that has compounded book value for decades — but at a 52-week high, an overbought RSI of 89, and a price *above* the Street's own $182.5 target, the risk/reward here is a Watch, not a buy: own the quality on… |
| EG Everest Group, Ltd. | Hold | 4 | 4 | 2 | — | +9.4% | $390 ($270–$500) | — | Everest is a cheap (7.6× earnings, 0.98× book), low-leverage, A+-rated global reinsurer that just posted a clean quarter (Q1'26 combined ratio 91.2%, 16.7% operating ROE) after a brutal 2024 reserve blowup — but it is a *cyclical underwriter shrinking premiums to defend margin*, not a growth… |
| TFC Truist Financial Corporation | Hold | 4 | 4 | 2 | — | +3.6% | $54 ($40–$66) | — | Truist is a large, cheap, well-capitalized Southeastern regional bank trading around book value with a ~4% dividend — a defensible income/value holding, but with a below-cost-of-capital ~8.5% ROE, only mid-teens forward EPS growth off a reset earnings base, cyclical credit exposure, and zero… |
| ALL The Allstate Corporation | Hold | 5 | 4 | 2 | — | +20.3% | $245 ($190–$300) | — | Allstate screens statistically cheap (5.5× trailing EPS, 0.19 beta) because it is a well-run cyclical insurer printing near-record underwriting profit off a *benign-catastrophe, reserve-release* quarter — but the Street's own estimates have EPS falling ~$30 → ~$25 through 2028 as that normalizes… |
| BAC Bank of America Corporation | Hold | 5 | 4 | 2 | — | +6.8% | $62 ($45–$76) | — | Bank of America is a cheap (14× earnings, 1.4× book), extremely well-capitalized (CET1 11.2%) megabank that is executing well — Q1'26 EPS +25%, ROTCE 16%, every segment growing — but it is a deeply cyclical, rate- and GDP-levered business with only ~10.5% ROE and mid-single-digit revenue growth… |
| KEY KeyCorp | Hold | 5 | 4 | 3 | — | +11.5% | $24 ($16–$30) | — | KeyCorp is a cleanly-recovering Cleveland regional bank — net interest margin re-expanding to 2.87%, fee businesses growing double-digits, CET1 11.4%, buybacks resumed — trading at a modest ~13–15× earnings and 1.25× book, but it is a mature, rate- and credit-cyclical bank with sub-10% ROE, no… |
| PRU Prudential Financial, Inc. | Hold | 5 | 4 | 2 | — | +0.1% | $115 ($82–$143) | — | Prudential is a cheap (11.5× earnings, 1.2× book), well-capitalised, 4.9%-yielding life insurer and asset manager (PGIM, $1.43T AUM) whose earnings are steady but structurally low-growth — the kind of name you own for the dividend and a possible re-rating toward book, not for capital appreciation… |
| RF Regions Financial Corporation | Hold | 5 | 4 | 2 | — | +11.7% | $32 ($23–$39) | — | Regions is a genuinely well-run, cheap (12.5× earnings, 3.5% yield), well-capitalized (CET1 10.7%) Southeast regional bank throwing off top-quartile returns (18% ROTCE) — but it is a low-growth, rate-sensitive, credit-cyclical business with no exponential engine, so the honest verdict is Watch: own… |
| TROW T. Rowe Price Group, Inc. | Hold | 5 | 3 | 2 | — | +15.8% | $108 ($82–$132) | — | T. Rowe Price is a high-quality, debt-free, 4.3%-yielding, 12.7× active asset manager that is *cheap for a reason* — assets under management still leak out the door ($13.7B of net outflows in Q1'26) and the effective fee rate keeps grinding lower, so earnings are flat-to-shrinking; the stock has… |
| BEN Franklin Resources, Inc. | Hold | 6 | 3 | 2 | — | +42.8% | $32 ($21–$42) | — | Franklin is a cheap-on-adjusted-earnings, 3.8%-yielding legacy active manager whose stock has re-rated 40% on AUM stabilization and an alternatives push — but forward EPS grows at low-single digits, GAAP margins have collapsed from ~27% to ~14%, and the whole model is structurally squeezed by… |
| AFL Aflac Incorporated | Avoid | 4 | 4 | 2 | — | +9.6% | $114 ($88–$128) | — | Aflac is a superbly-run, cash-generative supplemental-insurance compounder that has shrunk its share count ~26% in five years and carries almost no leverage — but reported revenue is *falling* (yen translation + a maturing Japan book), forward EPS growth is only ~4–5%, and at a fresh 52-week high… |